The Foundation on the frontline

We’re funding the future

Discoveries from past decades determine the way our kids are cared for right now. Perth Children’s Hospital Foundation and our generous donors fund researchers and research projects that will transform the future of child health.

We bring clinicians closer who are the best in their fields and support the translation of projects into clinical practice and fund prevention and early intervention research that drastically improves kid’s lives.

In 2020/21 we provided over $1.7 million in research grants. We fund clinical-based studies that focus on specialist areas of paediatric health to pioneer new ways of preventing, treating and curing life-limiting and life-threatening illnesses and conditions.

Perth Children's Hospital is the sole centre for treatment of children with cancer in Western Australia. Currently, over 100 new cases are diagnosed every year.

(L) Dr Daniel Yeoh, Paediatric Infectious Disease Physician, PCH (R) Professor Nick Gottardo - Stan Perron Chair of Paediatric Haemotology and Oncology, PCH
PACIFIC Study Perth Children's Hospital Foundation
Play Video about PACIFIC Study Perth Children's Hospital Foundation

Thriving, not just surviving - improving outcomes for children with cancer

Professor Nick Gottardo is the remarkable man working tirelessly each and every day toward a 100% cure rate of brain cancer, which kills more children than any other disease.

A recipient of funding from Perth Children’s Hospital Foundation research grants, Professor Gottardo is a world leader in paediatric oncology (read: kids’ cancer) and is working hard to find a cure for Medulloblastoma: the most common brain cancer in children.

Nick and his research team are working to identify drugs that when combined with radiotherapy or chemotherapy will kill brain tumour cells more effectively and reduce the often serious side effects of treatment.

Through his extensive research, and thanks to Perth Children’s Hospital Foundation donors, Professor Gottardo is on track to launch a clinical world trial for a drug known as a cell cycle checkpoint kinase inhibitor. His research has shown that this drug makes radiotherapy and chemotherapy more effective for children suffering Medulloblastoma. The results of this trial could be momentous for children suffering from this disease.

Click here to learn about more of the incredible work we are helping fund to ensure children with cancer at Perth Children’s Hospital have the best possible care and chance to get well and stay well.

More ground-breaking research

Early Moves: Major recruitment milestone for Aus-first study.

Patient recruitment is officially closed for Early Moves, one of the biggest and longest-running studies of its kind. Around 3,000 babies were successfully recruited into ...
Read More →
Move to Improve

WA Kids ‘Move to Improve’.

Kids with long-term health conditions – ranging from cystic fibrosis through to cerebral palsy – have been hitting the surf at Brighton Beach this year, ...
Read More →
Staph treatment

Recruitment going strong in trial to improve golden Staph treatment.

Patient recruitment for a world-first global study aiming to improve treatment of Staphylococcus aureus – a bacterial infection commonly known as golden staph – is ...
Read More →
Scroll to Top